ChemRar Group took part in the VI International Forum of Oncology and Radiotherapy “FOR LIFE”

From September 11 to 15, the VI International Forum of Oncology and Radiotherapy “FOR LIFE” took place in Moscow. The event was supported by the Ministry of Health of the Russian Federation, the Ministry of Science and Higher Education of the Russian Federation, the Russian Academy of Sciences and leading scientific, medical, educational institutions, Russian and foreign professional communities.

As part of the exhibition exposition of the Russian Ministry of Industry and Trade, ChemRar Group presented a number of drugs for the treatment of oncological diseases, as well as innovative developments.

Elena Yakubova, medical director of ChemRar Group, took part in the business program of the oncohematology forum, where key methods for diagnosing and treating oncohematological diseases, the introduction of new high technologies into medical practice, etc. were discussed.

“The meeting of oncohematology inspired us for further research; we confirmed the importance and relevance of our developments. The problems that the ChemRar team solves today are at the forefront of science and the needs of healthcare and patients in this area,” said Elena Yakubova. “We must do everything possible to ensure that innovative drugs for the treatment of cancer are developed in our country and bring them to market as quickly as possible so that our patients have access to advanced technologies among the first in the world.”

The ChemRar Goup is a leading developer of medicines in Russia with more than 30 years of history. ChemRar group organizations carry out a full cycle of research, development and production of innovative and import-substituting medicines in Russia and with partners around the world. The main focus of ChemRar Group is innovations in the treatment of virological, oncological diseases, as well as diseases of the central nervous system.

Since 2020, the ChemRar Group has been developing international activities in the following areas:

  • supplies of drugs for the treatment of oncological, autoimmune, infectious, neurological and other diseases;
  • transfer of production technologies for finished dosage forms to production sites abroad;
  • planning projects using the Build — Operate — Transfer model;
  • joint research projects on the development of medicines with foreign partners.

The geography of export activities covers over 40 countries in various regions of the world, including Latin America, the Middle East, Africa, South and Southeast Asia, where our own drugs have already been registered. ChemRar Group of Companies is interested in establishing and developing contacts with foreign pharmaceutical manufacturers, distributors of medicines, government customers, and representatives of ministries of health.

Contact Information:

Tel.: +7 495 925 30 74 #465

Email :

Ajax Call Form